| 1 | [SID103165933] | Active | IC50 | 0.2 | Concentration that inhibits binding of 1.5 nM [3H]diazepam to rat brain benzodiazepine receptor [AID40230, Type: Literature] | |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | IC50 | 0.2 [uM] | | BioAssay | Concentration that inhibits binding of 1.5 nM [3H]diazepam to rat brain benzodiazepine receptor | | AID | 40230 | | BioAssay type | Literature | | Target | | | PubMed | 2540330 | | Data Table |  |
|
| 2 | [SID103165933] | Active | IC50 | 0.2 | Inhibition of specific binding of 1.5 nM [3H]diazepam to rat brain benzodiazepine receptors [AID40519, Type: Literature] | |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | IC50 | 0.2 [uM] | | BioAssay | Inhibition of specific binding of 1.5 nM [3H]diazepam to rat brain benzodiazepine receptors | | AID | 40519 | | BioAssay type | Literature | | Target | | | PubMed | 1967311 | | Data Table |  |
|
| 3 | [SID103165933] | Active | IC50 | 0.2 | Inhibitory concentration against specific binding of [3H]diazepam to Benzodiazepine receptor in rat brain [AID40521, Type: Literature] | |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | IC50 | 0.2 [uM] | | BioAssay | Inhibitory concentration against specific binding of [3H]diazepam to Benzodiazepine receptor in rat brain | | AID | 40521 | | BioAssay type | Literature | | Target | | | PubMed | 2163452 | | Data Table |  |
|
| 4 | [SID103165933] | Active | IC50 | 0.248 | In vitro for inhibition of [3H]diazepam towards Benzodiazepine receptor from rat [AID40661, Type: Literature] | |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | IC50 | 0.248 [uM] | | BioAssay | In vitro for inhibition of [3H]diazepam towards Benzodiazepine receptor from rat | | AID | 40661 | | BioAssay type | Literature | | Target | | | PubMed | 6113284 | | Data Table |  |
|
| 5 | [SID103165933] | Active | Ki | 0.275 | Binding affinity by displacement of [3H]Ro-151788 from recombinant human gamma-aminobutyric-acid A receptor alpha3,beta3,gamma2 stably expressed in L cells [AID73245, Type: Literature] | Gamma-aminobutyric acid receptor subunit beta-3 [gi:120773] |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | Ki | 0.275 [uM] | | BioAssay | Binding affinity by displacement of [3H]Ro-151788 from recombinant human gamma-aminobutyric-acid A receptor alpha3,beta3,gamma2 stably expressed in L cells | | AID | 73245 | | BioAssay type | Literature | | Target | Gamma-aminobutyric acid receptor subunit beta-3 [gi:120773] | | PubMed | 11960500 | | Data Table |  |
|
| 6 | [SID103165933] | Active | Ki | 0.32 | Inhibition of [3H]Ro-151788 binding to human GABA A receptor (alpha-5-beta-3-gamma-2) stably expressed in L(tk-) cells. [AID73526, Type: Literature] | |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | Ki | 0.32 [uM] | | BioAssay | Inhibition of [3H]Ro-151788 binding to human GABA A receptor (alpha-5-beta-3-gamma-2) stably expressed in L(tk-) cells. | | AID | 73526 | | BioAssay type | Literature | | Target | | | PubMed | 11960500 | | Data Table |  |
|
| 7 | [SID103165933] | Active | IC50 | 0.33 | Inhibition of [3H]flunitrazepam binding to GABA-A benzodiazepine receptor of rat cerebral cortex [AID40231, Type: Literature] | Gamma-aminobutyric acid receptor subunit alpha-2 [gi:120758] |   View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | IC50 | 0.33 [uM] | | BioAssay | Inhibition of [3H]flunitrazepam binding to GABA-A benzodiazepine receptor of rat cerebral cortex | | AID | 40231 | | BioAssay type | Literature | | Target | Gamma-aminobutyric acid receptor subunit alpha-2 [gi:120758] | | PubMed | 2573731 | | Data Table |  |
|
| 8 | [SID103165933] | Active | Ki | 0.368 | Inhibition of [3H]-Ro- 15-1788 binding to recombinant human gamma-aminobutyric-acid A receptor alpha-5-beta-3-gamma-2 [AID73380, Type: Literature] | Gamma-aminobutyric acid receptor subunit beta-3 [gi:120773] |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | Ki | 0.368 [uM] | | BioAssay | Inhibition of [3H]-Ro- 15-1788 binding to recombinant human gamma-aminobutyric-acid A receptor alpha-5-beta-3-gamma-2 | | AID | 73380 | | BioAssay type | Literature | | Target | Gamma-aminobutyric acid receptor subunit beta-3 [gi:120773] | | PubMed | 15125950 | | Data Table |  |
|
| 9 | [SID103165933] | Active | Ki | 0.368 | Displacement of [3H]-Ro- 15-1788 from human gamma-aminobutyric-acid GABA-A receptor alpha-5-beta-3-gamma-2 expressed in L(tk-) cells [AID239702, Type: Literature] | Gamma-aminobutyric acid receptor subunit beta-3 [gi:120773] |   View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | Ki | 0.368 [uM] | | BioAssay | Displacement of [3H]-Ro- 15-1788 from human gamma-aminobutyric-acid GABA-A receptor alpha-5-beta-3-gamma-2 expressed in L(tk-) cells | | AID | 239702 | | BioAssay type | Literature | | Target | Gamma-aminobutyric acid receptor subunit beta-3 [gi:120773] | | PubMed | 15537339 | | Data Table |  |
|
| 10 | [SID103165933] | Active | Ki | 0.392 | Displacement of [3H]-Ro- 15-1788 from human gamma-aminobutyric-acid GABA-A receptor alpha-2-beta-3-gamma-2 expressed in L(tk-) cells [AID239700, Type: Literature] | Gamma-aminobutyric acid receptor subunit beta-3 [gi:120773] |   View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | Ki | 0.392 [uM] | | BioAssay | Displacement of [3H]-Ro- 15-1788 from human gamma-aminobutyric-acid GABA-A receptor alpha-2-beta-3-gamma-2 expressed in L(tk-) cells | | AID | 239700 | | BioAssay type | Literature | | Target | Gamma-aminobutyric acid receptor subunit beta-3 [gi:120773] | | PubMed | 15537339 | | Data Table |  |
|
| 11 | [SID103165933] | Active | Ki | 0.392 | Inhibition of [3H]-Ro- 15-1788 binding to recombinant human gamma-aminobutyric-acid A receptor alpha-2-beta-3-gamma-2 [AID73080, Type: Literature] | Gamma-aminobutyric acid receptor subunit beta-3 [gi:120773] |   View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | Ki | 0.392 [uM] | | BioAssay | Inhibition of [3H]-Ro- 15-1788 binding to recombinant human gamma-aminobutyric-acid A receptor alpha-2-beta-3-gamma-2 | | AID | 73080 | | BioAssay type | Literature | | Target | Gamma-aminobutyric acid receptor subunit beta-3 [gi:120773] | | PubMed | 15125950 | | Data Table |  |
|
| 12 | [SID103165933] | Active | Ki | 0.438 | Binding affinity against rat benzodiazepine (BZD) receptor [AID39933, Type: Literature] | |   View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | Ki | 0.438 [uM] | | BioAssay | Binding affinity against rat benzodiazepine (BZD) receptor | | AID | 39933 | | BioAssay type | Literature | | Target | | | PubMed | 12372538 | | Data Table |  |
|
| 13 | [SID103165933] | Active | IC50 | 0.442 | Inhibition of binding of tritiated 3[H]diazepam radioligand to rat brain homogenates [AID40833, Type: Literature] | |   View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | IC50 | 0.442 [uM] | | BioAssay | Inhibition of binding of tritiated 3[H]diazepam radioligand to rat brain homogenates | | AID | 40833 | | BioAssay type | Literature | | Target | | | PubMed | 6304314 | | Data Table |  |
|
| 14 | [SID103165933] | Active | Ki | 0.46 | Displacement of [3H]Ro-151788 from human Gamma-aminobutyric acid A receptor alpha-2-beta-3-gamma-2 stably expressed in L(tk-) cells [AID73090, Type: Literature] | |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | Ki | 0.46 [uM] | | BioAssay | Displacement of [3H]Ro-151788 from human Gamma-aminobutyric acid A receptor alpha-2-beta-3-gamma-2 stably expressed in L(tk-) cells | | AID | 73090 | | BioAssay type | Literature | | Target | | | PubMed | 11960500 | | Data Table |  |
|
| 15 | [SID103165933] | Active | Ki | 0.46 | Displacement of [3H]-Ro- 15-1788 from human GABA-A alpha-2-beta-3-gamma-2 receptor subunits expressed in Xenopus oocytes [AID73081, Type: Literature] | Gamma-aminobutyric acid receptor subunit beta-3 [gi:120773] |   View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | Ki | 0.46 [uM] | | BioAssay | Displacement of [3H]-Ro- 15-1788 from human GABA-A alpha-2-beta-3-gamma-2 receptor subunits expressed in Xenopus oocytes | | AID | 73081 | | BioAssay type | Literature | | Target | Gamma-aminobutyric acid receptor subunit beta-3 [gi:120773] | | PubMed | 15084116 | | Data Table |  |
|
| 16 | [SID103165933] | Active | Ki | 0.471 | Inhibition of [3H]-Ro- 15-1788 binding to recombinant human gamma-aminobutyric-acid A receptor alpha-3-beta-3-gamma-2 [AID73235, Type: Literature] | Gamma-aminobutyric acid receptor subunit beta-3 [gi:120773] |   View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | Ki | 0.471 [uM] | | BioAssay | Inhibition of [3H]-Ro- 15-1788 binding to recombinant human gamma-aminobutyric-acid A receptor alpha-3-beta-3-gamma-2 | | AID | 73235 | | BioAssay type | Literature | | Target | Gamma-aminobutyric acid receptor subunit beta-3 [gi:120773] | | PubMed | 15125950 | | Data Table |  |
|
| 17 | [SID103165933] | Active | Ki | 0.471 | Displacement of [3H]-Ro- 15-1788 from human gamma-aminobutyric-acid GABA-A receptor alpha-3-beta-3-gamma-2 expressed in L(tk-) cells [AID239701, Type: Literature] | Gamma-aminobutyric acid receptor subunit beta-3 [gi:120773] |   View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | Ki | 0.471 [uM] | | BioAssay | Displacement of [3H]-Ro- 15-1788 from human gamma-aminobutyric-acid GABA-A receptor alpha-3-beta-3-gamma-2 expressed in L(tk-) cells | | AID | 239701 | | BioAssay type | Literature | | Target | Gamma-aminobutyric acid receptor subunit beta-3 [gi:120773] | | PubMed | 15537339 | | Data Table |  |
|
| 18 | [SID103165933] | Active | Ki | 0.52 | Displacement of [3H]-Ro- 15-1788 from human GABA-A alpha-5-beta-3-gamma-2 receptor subunits expressed in Xenopus oocytes [AID73382, Type: Literature] | Gamma-aminobutyric acid receptor subunit beta-3 [gi:120773] |   View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | Ki | 0.52 [uM] | | BioAssay | Displacement of [3H]-Ro- 15-1788 from human GABA-A alpha-5-beta-3-gamma-2 receptor subunits expressed in Xenopus oocytes | | AID | 73382 | | BioAssay type | Literature | | Target | Gamma-aminobutyric acid receptor subunit beta-3 [gi:120773] | | PubMed | 15084116 | | Data Table |  |
|
| 19 | [SID103165933] | Active | Ki | 0.56 | Inhibition of [3H]Ro-151788 binding to human GABA A receptor (alpha-1-beta-3-gamma-2) stably expressed in L(tk-) cells. [AID72930, Type: Literature] | |   View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | Ki | 0.56 [uM] | | BioAssay | Inhibition of [3H]Ro-151788 binding to human GABA A receptor (alpha-1-beta-3-gamma-2) stably expressed in L(tk-) cells. | | AID | 72930 | | BioAssay type | Literature | | Target | | | PubMed | 11960500 | | Data Table |  |
|
| 20 | [SID103165933] | Active | Ki | 0.605 | Displacement of [3H]-Ro- 15-1788 from human gamma-aminobutyric-acid GABA-A receptor alpha-1-beta-3-gamma-2 expressed in L(tk-) cells [AID239699, Type: Literature] | Gamma-aminobutyric acid receptor subunit beta-3 [gi:120773] |   View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | Ki | 0.605 [uM] | | BioAssay | Displacement of [3H]-Ro- 15-1788 from human gamma-aminobutyric-acid GABA-A receptor alpha-1-beta-3-gamma-2 expressed in L(tk-) cells | | AID | 239699 | | BioAssay type | Literature | | Target | Gamma-aminobutyric acid receptor subunit beta-3 [gi:120773] | | PubMed | 15537339 | | Data Table |  |
|
| 21 | [SID103165933] | Active | Ki | 0.605 | Inhibition of [3H]-Ro- 15-1788 binding to recombinant human gamma-aminobutyric-acid A receptor alpha-1-beta-3-gamma-2 [AID72918, Type: Literature] | Gamma-aminobutyric acid receptor subunit beta-3 [gi:120773] |   View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | Ki | 0.605 [uM] | | BioAssay | Inhibition of [3H]-Ro- 15-1788 binding to recombinant human gamma-aminobutyric-acid A receptor alpha-1-beta-3-gamma-2 | | AID | 72918 | | BioAssay type | Literature | | Target | Gamma-aminobutyric acid receptor subunit beta-3 [gi:120773] | | PubMed | 15125950 | | Data Table |  |
|
| 22 | [SID103165933] | Active | IC50 | 0.71 | Displacement of [3H]flunitrazepam from GABA-A benzodiazepine receptor of rat cerebral cortex membrane [AID40227, Type: Literature] | |   View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | IC50 | 0.71 [uM] | | BioAssay | Displacement of [3H]flunitrazepam from GABA-A benzodiazepine receptor of rat cerebral cortex membrane | | AID | 40227 | | BioAssay type | Literature | | Target | | | PubMed | 1681105 | | Data Table |  |
|
| 23 | [SID103165933] | Active | Ki | 0.74 | Displacement of [3H]-Ro- 15-1788 from human GABA-A alpha-3-beta-3-gamma-2 receptor subunits expressed in Xenopus oocytes [AID73236, Type: Literature] | Gamma-aminobutyric acid receptor subunit beta-3 [gi:120773] |   View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | Ki | 0.74 [uM] | | BioAssay | Displacement of [3H]-Ro- 15-1788 from human GABA-A alpha-3-beta-3-gamma-2 receptor subunits expressed in Xenopus oocytes | | AID | 73236 | | BioAssay type | Literature | | Target | Gamma-aminobutyric acid receptor subunit beta-3 [gi:120773] | | PubMed | 15084116 | | Data Table |  |
|
| 24 | [SID103165933] | Active | Ki | 0.77 | Displacement of [3H]-Ro- 15-1788 from human GABA-A alpha-1-beta-3-gamma-2 receptor subunits expressed in Xenopus oocytes [AID72919, Type: Literature] | Gamma-aminobutyric acid receptor subunit beta-3 [gi:120773] |   View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | Ki | 0.77 [uM] | | BioAssay | Displacement of [3H]-Ro- 15-1788 from human GABA-A alpha-1-beta-3-gamma-2 receptor subunits expressed in Xenopus oocytes | | AID | 72919 | | BioAssay type | Literature | | Target | Gamma-aminobutyric acid receptor subunit beta-3 [gi:120773] | | PubMed | 15084116 | | Data Table |  |
|
| 25 | [SID103165933] | Active | IC50 | 0.79 | Displacement of 3[H]Flunitrazepam from GABA-A central benzodiazepine receptor of bovine brain membranes [AID41994, Type: Literature] | |   View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | IC50 | 0.79 [uM] | | BioAssay | Displacement of 3[H]Flunitrazepam from GABA-A central benzodiazepine receptor of bovine brain membranes | | AID | 41994 | | BioAssay type | Literature | | Target | | | PubMed | 2821257 | | Data Table |  |
|
| 26 | [SID103165933] | Active | IC50 | 0.79 | Inhibition of [3H]flunitrazepam binding to benzodiazepine receptor in bovine brain membrane [AID41998, Type: Literature] | Gamma-aminobutyric acid receptor subunit alpha-1 [gi:120752] |   View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | IC50 | 0.79 [uM] | | BioAssay | Inhibition of [3H]flunitrazepam binding to benzodiazepine receptor in bovine brain membrane | | AID | 41998 | | BioAssay type | Literature | | Target | Gamma-aminobutyric acid receptor subunit alpha-1 [gi:120752] | | PubMed | 2826782 | | Data Table |  |
|
| 27 | [SID103165933] | Active | IC50 | 0.91 | Displacement of [3H]flunitrazepam from GABA-A benzodiazepine receptor in synaptic membranes of rat cerebral cortex [AID40835, Type: Literature] | Gamma-aminobutyric acid receptor subunit alpha-2 [gi:120758] |   View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | IC50 | 0.91 [uM] | | BioAssay | Displacement of [3H]flunitrazepam from GABA-A benzodiazepine receptor in synaptic membranes of rat cerebral cortex | | AID | 40835 | | BioAssay type | Literature | | Target | Gamma-aminobutyric acid receptor subunit alpha-2 [gi:120758] | | PubMed | 2985787 | | Data Table |  |
|
| 28 | [SID103165933] | Active | IC50 | 1.1 | Inhibition of [3H]flunitrazepam binding to GABA-A central Benzodiazepine receptor of bovine brain membranes [AID41996, Type: Literature] | Gamma-aminobutyric acid receptor subunit alpha-1 [gi:120752] |   View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | IC50 | 1.1 [uM] | | BioAssay | Inhibition of [3H]flunitrazepam binding to GABA-A central Benzodiazepine receptor of bovine brain membranes | | AID | 41996 | | BioAssay type | Literature | | Target | Gamma-aminobutyric acid receptor subunit alpha-1 [gi:120752] | | PubMed | 2984422 | | Data Table |  |
|
| 29 | [SID103165933] | Active | IC50 | 1.429 | DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam) [AID625261, Type: other] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | IC50 | 1.429 [uM] | | BioAssay | DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam) | | AID | 625261 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID103165933] | Active | IC50 | 1.795 | DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) [AID625269, Type: other] | Histamine H1 receptor [gi:547645] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | IC50 | 1.795 [uM] | | BioAssay | DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) | | AID | 625269 | | BioAssay type | other | | Target | Histamine H1 receptor [gi:547645] | | PubMed | | | Data Table |  |
|
| 31 | [SID103165933] | Active | IC50 | 1.795 | DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) [AID625269, Type: other] | Histamine H1 receptor [gi:547645] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | IC50 | 1.795 [uM] | | BioAssay | DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) | | AID | 625269 | | BioAssay type | other | | Target | Histamine H1 receptor [gi:547645] | | PubMed | | | Data Table |  |
|
| 32 | [SID49648393] | Active | | | Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling [AID588675, Type: screening] | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49648393 | | CID | 2712 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling | | AID | 588675 | | BioAssay type | screening | | Target | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] | | PubMed | | | Data Table |  |
|
| 33 | [SID49648393] | Active | | | Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling [AID588675, Type: screening] | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49648393 | | CID | 2712 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling | | AID | 588675 | | BioAssay type | screening | | Target | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] | | PubMed | | | Data Table |  |
|
| 34 | [SID103165933] | Active | | | Activity in rat elevated plus maze assay at 5 mg/kg, ip [AID259155, Type: Literature] | |   View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | BioAssay | Activity in rat elevated plus maze assay at 5 mg/kg, ip | | AID | 259155 | | BioAssay type | Literature | | Target | | | PubMed | 16392789 | | Data Table |  |
|
| 35 | [SID103165933] | Active | | | Binding constant was determined by displacing potential to [3H]-diazepam binding in cerebral cortex homogenates of rat [AID40839, Type: Literature] | |   View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | BioAssay | Binding constant was determined by displacing potential to [3H]-diazepam binding in cerebral cortex homogenates of rat | | AID | 40839 | | BioAssay type | Literature | | Target | | | PubMed | 2861285 | | Data Table |  |
|
| 36 | [SID103165933] | Active | | | Mouse behavior activity was determined; D = Depressant [AID134938, Type: Literature] | |   View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Active | | BioAssay | Mouse behavior activity was determined; D = Depressant | | AID | 134938 | | BioAssay type | Literature | | Target | | | PubMed | 6716399 | | Data Table |  |
|
| 37 | [SID48415753] | Active | | | DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database [AID1195, Type: other] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 48415753 | | CID | 2712 | | Outcome | Active | | BioAssay | DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database | | AID | 1195 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID103856643] | Active | | | Wombat Data for BeliefDocking [AID493017, Type: Literature] | [geneid:2554] |   View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 103856643 | | CID | 2712 | | Outcome | Active | | BioAssay | Wombat Data for BeliefDocking | | AID | 493017 | | BioAssay type | Literature | | Target | [geneid:2554] | | PubMed | 11960500 | | Data Table |  |
|
| 39 | [SID103856643] | Active | | | Wombat Data for BeliefDocking [AID493017, Type: Literature] | [geneid:2554] |   View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 103856643 | | CID | 2712 | | Outcome | Active | | BioAssay | Wombat Data for BeliefDocking | | AID | 493017 | | BioAssay type | Literature | | Target | [geneid:2554] | | PubMed | 11960500 | | Data Table |  |
|
| 40 | [SID103165933] | Unspecified | IC50 | 100 | Inhibition of binding of [125I]gastrin to guinea pig gastric glands [AID76082, Type: Literature] | |   View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Unspecified | | IC50 | 100 [uM] | | BioAssay | Inhibition of binding of [125I]gastrin to guinea pig gastric glands | | AID | 76082 | | BioAssay type | Literature | | Target | | | PubMed | 3336026 | | Data Table |  |
|
| 41 | [SID103165933] | Unspecified | IC50 | 100 | Binding affinity towards cholecystokinin receptor by displacement of [125I]CCK-33 from guinea pig brain tissue [AID52277, Type: Literature] | |   View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Unspecified | | IC50 | 100 [uM] | | BioAssay | Binding affinity towards cholecystokinin receptor by displacement of [125I]CCK-33 from guinea pig brain tissue | | AID | 52277 | | BioAssay type | Literature | | Target | | | PubMed | 3336026 | | Data Table |  |
|
| 42 | [SID103165933] | Unspecified | IC50 | 100 | Binding affinity towards cholecystokinin receptor by the displacement of [125I]CCK-33 in rat pancreatic tissue [AID52418, Type: Literature] | |   View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Unspecified | | IC50 | 100 [uM] | | BioAssay | Binding affinity towards cholecystokinin receptor by the displacement of [125I]CCK-33 in rat pancreatic tissue | | AID | 52418 | | BioAssay type | Literature | | Target | | | PubMed | 3336026 | | Data Table |  |
|
| 43 | [SID103165933] | Unspecified | | | Modulatory effect on coapplication with GABA at human Gamma-aminobutyric acid A receptor alpha-1-beta-3-gamma-2 in Xenopus oocyte. [AID72922, Type: Literature] | |   View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Unspecified | | BioAssay | Modulatory effect on coapplication with GABA at human Gamma-aminobutyric acid A receptor alpha-1-beta-3-gamma-2 in Xenopus oocyte. | | AID | 72922 | | BioAssay type | Literature | | Target | | | PubMed | 11960500 | | Data Table |  |
|
| 44 | [SID103165933] | Unspecified | | | Volume of distribution at steady state in human after iv administration [AID540209, Type: Literature] | |   View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Unspecified | | BioAssay | Volume of distribution at steady state in human after iv administration | | AID | 540209 | | BioAssay type | Literature | | Target | | | PubMed | 18426954 | | Data Table |  |
|
| 45 | [SID103165933] | Unspecified | | | Clearance in human after iv administration [AID540210, Type: Literature] | |   View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Unspecified | | BioAssay | Clearance in human after iv administration | | AID | 540210 | | BioAssay type | Literature | | Target | | | PubMed | 18426954 | | Data Table |  |
|
| 46 | [SID103165933] | Unspecified | | | Fraction unbound in human after iv administration [AID540211, Type: Literature] | |   View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Unspecified | | BioAssay | Fraction unbound in human after iv administration | | AID | 540211 | | BioAssay type | Literature | | Target | | | PubMed | 18426954 | | Data Table |  |
|
| 47 | [SID103165933] | Unspecified | | | Mean residence time in human after iv administration [AID540212, Type: Literature] | |   View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Unspecified | | BioAssay | Mean residence time in human after iv administration | | AID | 540212 | | BioAssay type | Literature | | Target | | | PubMed | 18426954 | | Data Table |  |
|
| 48 | [SID103165933] | Unspecified | | | Half life in human after iv administration [AID540213, Type: Literature] | |   View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Unspecified | | BioAssay | Half life in human after iv administration | | AID | 540213 | | BioAssay type | Literature | | Target | | | PubMed | 18426954 | | Data Table |  |
|
| 49 | [SID103165933] | Unspecified | | | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans [AID588211, Type: Literature] | |   View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Unspecified | | BioAssay | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans | | AID | 588211 | | BioAssay type | Literature | | Target | | | PubMed | 20014752 | | Data Table |  |
|
| 50 | [SID103165933] | Unspecified | | | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents [AID588212, Type: Literature] | |   View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 103165933 | | CID | 2712 | | Outcome | Unspecified | | BioAssay | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents | | AID | 588212 | | BioAssay type | Literature | | Target | | | PubMed | 20014752 | | Data Table |  |
|